Cash · 2018–2025

Adaptive Biotechnologies cash

$70.5M+47.1% · FY2025

Adaptive Biotechnologies (ADPT) reported $70.5M in cash for fiscal 2025, +47.1% year on year.

$55.0M2018$96.6M2019$123M2020$139M2021$90.0M2022$65.1M2023$47.9M2024$70.5M2025
Adaptive Biotechnologies — Cash, 2018–2025
Fiscal yearCashChangeFiling
FY20252025-12-31$70.5M+47.1%Open →
FY20242024-12-31$47.9M−26.3%Open →
FY20232023-12-31$65.1M−27.7%Open →
FY20222022-12-31$90.0M−35.3%Open →
FY20212021-12-31$139M+12.7%Open →
FY20202020-12-31$123M+27.8%Open →
FY20192019-12-31$96.6M+75.5%Open →
FY20182018-12-31$55.0M—Open →

Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2018–2025 compound annual growth +3.6%

Cash at companies of similar size

Full ranking by cash →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Adaptive Biotechnologies cash |url=https://companiesranked.com/en/company/adaptive-biotechnologies/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Adaptive Biotechnologies cash. CompaniesRanked. https://companiesranked.com/en/company/adaptive-biotechnologies/cash-on-hand

BibTeX

@misc{companiesranked-en-company-adaptive-biotechnologies-cash-on-hand-2026,
  author       = {{CompaniesRanked}},
  title        = {{Adaptive Biotechnologies cash}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/adaptive-biotechnologies/cash-on-hand}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001193125-26-332940 · August 4, 2026

{{cite web |title=Adaptive Biotechnologies cash — 10-Q (0001193125-26-332940) |url=https://www.sec.gov/Archives/edgar/data/1478320/000119312526332940/adpt-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-04}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Adaptive Biotechnologies overview